Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlotte Genestet

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Tuberculosis (Edinburgh, Scotland)|July 22, 2018
Antituberculous drugs modulate bacterial phagolysosome avoidance and autophagy in Mycobacterium tuberculosis-infected macrophagesCharlotte Genestet, Fanny Bernard-Barret, Elisabeth Hodille, et al.
Microbiology Spectrum|April 25, 2022
Consistency of Mycobacterium tuberculosis Complex Spoligotyping between the Membrane-Based Method and <i>In Silico</i> ApproachCharlotte Genestet, Elisabeth Hodille, Albin Bernard, et al.
International Journal of Antimicrobial Agents|January 29, 2020
Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, FranceCharlotte Genestet, Elisabeth Hodille, Jean-Luc Berland, et al.
Scientific Reports|May 27, 2021
Assessment of closely related Mycobacterium tuberculosis variants with different transmission success and in vitro infection dynamicsEstefanía Abascal, Charlotte Genestet, Ana Valera, et al.
Pathogens (Basel, Switzerland)|February 10, 2021
The MTB/MDR ELITe MGB<sup>®</sup> Kit: Performance Assessment for Pulmonary, Extra-Pulmonary, and Resistant Tuberculosis Diagnosis, and Integration in the Laboratory Workflow of a French CenterElisabeth Hodille, Charlotte Genestet, Thomas Delque, et al.
Microbiologyopen|March 20, 2026
NCY-1 β-Lactamase Activity Correlates With Antimicrobial Susceptibility of a Clinical Strain of Nocardia cyriacigeorgicaJulie Couston, Athénaïs Le Marchand, Elisabeth Hodille, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 26, 2019
Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centreElisabeth Hodille, Audey Maisson, Laurine Charlet, et al.
Antimicrobial Agents and Chemotherapy|July 19, 2021
Population Pharmacokinetic Modeling and Dosing Simulations of Tobramycin in Pediatric Patients with Cystic FibrosisAntonin Praet, Laurent Bourguignon, Florence Vetele, et al.
Tuberculosis (Edinburgh, Scotland)|June 3, 2019
Subcultured Mycobacterium tuberculosis isolates on different growth media are fully representative of bacteria within clinical samplesCharlotte Genestet, Elisabeth Hodille, Emilie Westeel, et al.
Heliyon|May 10, 2024
Rapid resistance detection is reliable for prompt adaptation of isoniazid resistant tuberculosis managementOlivier Bahuaud, Charlotte Genestet, Elisabeth Hodille, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Tuberculosis (Edinburgh, Scotland)|July 22, 2018
Antituberculous drugs modulate bacterial phagolysosome avoidance and autophagy in Mycobacterium tuberculosis-infected macrophagesCharlotte Genestet, Fanny Bernard-Barret, Elisabeth Hodille, et al.
Microbiology Spectrum|April 25, 2022
Consistency of Mycobacterium tuberculosis Complex Spoligotyping between the Membrane-Based Method and <i>In Silico</i> ApproachCharlotte Genestet, Elisabeth Hodille, Albin Bernard, et al.
International Journal of Antimicrobial Agents|January 29, 2020
Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, FranceCharlotte Genestet, Elisabeth Hodille, Jean-Luc Berland, et al.
Scientific Reports|May 27, 2021
Assessment of closely related Mycobacterium tuberculosis variants with different transmission success and in vitro infection dynamicsEstefanía Abascal, Charlotte Genestet, Ana Valera, et al.
Pathogens (Basel, Switzerland)|February 10, 2021
The MTB/MDR ELITe MGB<sup>®</sup> Kit: Performance Assessment for Pulmonary, Extra-Pulmonary, and Resistant Tuberculosis Diagnosis, and Integration in the Laboratory Workflow of a French CenterElisabeth Hodille, Charlotte Genestet, Thomas Delque, et al.
Microbiologyopen|March 20, 2026
NCY-1 β-Lactamase Activity Correlates With Antimicrobial Susceptibility of a Clinical Strain of Nocardia cyriacigeorgicaJulie Couston, Athénaïs Le Marchand, Elisabeth Hodille, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 26, 2019
Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centreElisabeth Hodille, Audey Maisson, Laurine Charlet, et al.
Antimicrobial Agents and Chemotherapy|July 19, 2021
Population Pharmacokinetic Modeling and Dosing Simulations of Tobramycin in Pediatric Patients with Cystic FibrosisAntonin Praet, Laurent Bourguignon, Florence Vetele, et al.
Tuberculosis (Edinburgh, Scotland)|June 3, 2019
Subcultured Mycobacterium tuberculosis isolates on different growth media are fully representative of bacteria within clinical samplesCharlotte Genestet, Elisabeth Hodille, Emilie Westeel, et al.
Heliyon|May 10, 2024
Rapid resistance detection is reliable for prompt adaptation of isoniazid resistant tuberculosis managementOlivier Bahuaud, Charlotte Genestet, Elisabeth Hodille, et al.
Pageof 3